During its 155th Session, held in Strasbourg on 21-22 June 2016, the European Pharmacopoeia (Ph. Eur.) Commission adopted a revision of the general chapter Monocyteactivation test (2.6.30) in order to make it more widely useable by stakeholders and thus facilitate a reduction in testing on laboratory animals.